The role of interleukin-33 in patients with mild cognitive impairment and Alzheimer’s disease | Alzheimer's Research & Therapy | Full Text

The role of interleukin-33 in patients with mild cognitive impairment and Alzheimer’s disease | Alzheimer's Research & Therapy | Full Text

The role of interleukin-33 in patients with mild cognitive impairment and Alzheimer’s disease

The neuroprotective role of interleukin (IL)-33 is supported by numerous preclinical studies, but it remains uninvestigated in clinical studies of Alzheimer’s disease (AD). We aimed to examine the association ...

Authors:Chih-Sung Liang, Kuan-Pin Su, Chia-Lin Tsai, Jiunn-Tay Lee, Che-Sheng Chu, Ta-Chuan Yeh, Ming-Wei Su, Guan-Yu Lin, Yu-Kai Lin, Hsuan-Te Chu, Chia-Kuang Tsai and Fu-Chi Yang

Citation:Alzheimer's Research & Therapy 2020 12:86

Content type:Research

 

Published on: 16 July 2020

• ViewFull Text
 
• ViewPDF